Skip to main content

Evolv Technology Reports First Quarter Financial Results

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

— Company Raises Outlook for 2026 —

  • Q1'26 Revenue of $46.3 million, up 45% year-over-year
  • Q1'26 Ending ARR1 of $127.3 million, up 20% year-over-year
  • Q1'26 Net Loss of $(5.0) million, with Net Profit Margin of (10.8)%
  • Q1'26 Adjusted EBITDA2 of $3.9 million, with Adjusted EBITDA Margin2 of 8.5%

Evolv Technologies Holdings, Inc (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended March 31, 2026.

“Our first quarter results reflect our progress in building a disciplined and predictable business,” said John Kedzierski, President and Chief Executive Officer of Evolv Technology. “Revenue growth during the quarter was driven by new customer acquisition, expanding deployments within our installed base, and growing adoption of our newest product — Evolv eXpedite. Looking ahead, we remain focused on scaling the business and delivering weapon screening in complex, real-world environments across the growing customer base we are serving—helping make the world a better place to live, learn, work, and play.”

Results for the First Quarter of 2026

Total revenue for the first quarter of 2026 was $46.3 million, an increase of 45% compared to $32.0 million for the first quarter of 2025. Revenue for the first quarter of 2026 was primarily driven by strong new customer additions and continued expansion of deployments across the existing customer base. Annual Recurring Revenue (“ARR”)1 was $127.3 million at the end of first quarter of 2026, an increase of 20% compared to $106.0 million at the end of the first quarter of 2025. Net loss for the first quarter of 2026 was $(5.0) million, or $(0.03) per basic and diluted share, compared to net loss of $(1.7) million, or $(0.01) per basic and diluted share, in the first quarter of 2025. Adjusted loss2 for the first quarter of 2026 was $(3.3) million, or $(0.02) per diluted share, compared to adjusted loss2 of $(3.4) million, or $(0.02) per diluted share, for the first quarter of 2025. Adjusted EBITDA2 for the first quarter of 2026 was $3.9 million compared to $2.1 million in the first quarter of 2025. As of March 31, 2026, the Company had cash, cash equivalents and marketable securities of $61.1 million.

The following table summarizes the breakdown of recurring and non-recurring revenue3 for each period presented:

 

Three Months Ended

March 31,

 

 

2026

 

 

 

2025

 

 

% Change

Recurring revenue

$

31,176

 

$

25,753

 

21

%

Non-recurring revenue

 

15,152

 

 

6,254

 

142

%

Total revenue

$

46,328

 

$

32,007

 

45

%

The following table summarizes operating cash flows for each period presented:

 

Three Months Ended

March 31,

 

 

2026

 

 

 

2025

 

Net loss

$

(5,009

)

 

$

(1,689

)

Adjustments to reconcile net loss to net cash used in operating activities

 

9,604

 

 

 

(1,082

)

Changes in operating assets and liabilities

 

(7,774

)

 

 

232

 

Net cash used in operating activities

$

(3,179

)

 

$

(2,539

)

Company Comments on Outlook for 2026

The Company today commented on its business outlook for 2026. The Company's outlook is based on the current indications for its business, which may change at any time. The Company expects total revenues in 2026 to be between $175 to $180 million, reflecting growth of approximately 20% to 23% year-over-year. The Company expects ending ARR at December 31, 2026 to increase to approximately $145 to $150 million, reflecting growth of approximately 20% to 25% year-over-year. The Company currently expects approximately 45% of the Company’s new unit deployments in 2026 to be delivered under the Company’s pure subscription model, with the remaining 55% deployed through the Company’s purchase-subscription model. The Company expects to deliver positive full year Adjusted EBITDA1 in 2026 with Adjusted EBITDA1 margins in the high single digits.

Estimate

 

Issued March 10, 2026

 

Issued May 12, 2026

Total Revenue (Millions)

 

$172-$178

 

$175-$180

Ending ARR at 12/31/26 (Millions)

 

$145-$150

 

No Change

Adjusted EBITDA Margin2

 

High Single Digits

 

No Change

Company to Host Live Conference Call and Webcast

The Company’s management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management’s outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com.

About Evolv Technology

Evolv Technologies Holdings, Inc (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than four billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal’s (SBJ) 2024 awards for “Best In Fan Experience Technology” and “Best In Sports Technology”. Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

1 We define Annual Recurring Revenue, or ARR, as the sum of subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter all multiplied by twelve. The amount of revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly due to differences in our recurring and non-recurring revenue streams. To the extent that we are negotiating a renewal or upgrade with a customer after the expiration of the subscription and we are continuing to provide service to that customer, we may continue to include that associated revenue in ARR. If a customer notifies us that it is not renewing its subscription, we will continue to include associated revenue in ARR through the natural expiration of the subscription term. ARR should be viewed independently of, and not as a substitute for or forecast of, revenue or deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

2 Non-GAAP Financial Measures In this press release, the Company’s adjusted operating expenses, adjusted gross profit (loss), adjusted gross margin, adjusted operating income (loss), adjusted EBITDA, adjusted EBITDA margin, adjusted earnings (loss), and adjusted earnings (loss) per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. Other non-recurring legal and regulatory costs include non-recurring legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain non-recurring regulatory, litigation and legal matters, as well as fees related to the resolution of the Securities and Exchange Commission investigation, net of estimated insurance recoveries. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense and amortization of capitalized stock-based compensation, which management believes provides a more meaningful representation of contribution margin. Adjusted operating income (loss) is defined as loss from operations, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA and Adjusted EBITDA margin is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), (benefit) provision for income taxes, change in fair value of contingent earn-out liability, change in fair value of contingently issuable/returnable common stock liability/asset, change in fair value of public warrant liability, loss on disposal of leased equipment, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted earnings (loss) and Adjusted earnings (loss) per diluted share are defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, change in fair value of contingent earn-out liability, change in fair value of contingently issuable/returnable common stock liability/asset, change in fair value of public warrant liability, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted EBITDA to Net Income (Loss) and Adjusted EBITDA Margin to Net Profit Margin, each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company’s control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable/returnable common stock liabilities/assets, and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company’s future financial results.

3 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is non-recurring in nature, such as product revenue, shipping revenue, revenue from installation, training, and professional services, and rental revenue.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, goals, business model, demand for our products, market opportunities, strategic partnerships, and future financial and operational results. Words such as “believe,” “may,” “will,” “expect,” “should,” “could,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “potential,” “continue,” “project,” “target,” “forecast,” “is/are likely to,” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the amount of insurance reimbursements expected to be received for defense costs for counsel and consultants in connection with the securities litigation and related Securities and Exchange Commission (the “SEC”) and Department of Justice matters, and the following: our history of losses and ability to reach profitability; our reliance on reseller partners; expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; our ability to renew customer contracts, our ability to renew customer contracts at terms favorable to the Company, the Company’s reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company’s intellectual property rights and use of “open source” software; the concentration of the Company’s revenues on a single solution; the Company’s ability to timely design, produce and launch its solutions, the Company’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company’s securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans and efforts, including related costs; risks related to increasing attention to and evolving expectations for sustainability initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed in our most recent report on Form 10-Q or 10-K filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(In thousands, except share and per share data)

(Unaudited)

 

 

 

 

 

Three Months Ended

March 31,

 

 

 

2026

 

 

 

2025

 

Revenue:

 

 

 

Product revenue

$

13,421

 

 

$

2,322

 

Subscription revenue

 

23,148

 

 

 

19,237

 

Service revenue

 

8,589

 

 

 

6,730

 

License fee and other revenue

 

1,170

 

 

 

3,718

 

Total revenue

 

46,328

 

 

 

32,007

 

Cost of revenue:

 

 

 

Cost of product revenue

 

11,856

 

 

 

3,184

 

Cost of subscription revenue

 

8,367

 

 

 

7,896

 

Cost of service revenue

 

2,192

 

 

 

1,705

 

Cost of license fee and other revenue

 

314

 

 

 

72

 

Total cost of revenue

 

22,729

 

 

 

12,857

 

Gross profit

 

23,599

 

 

 

19,150

 

Operating expenses:

 

 

 

Research and development

 

5,885

 

 

 

4,862

 

Sales and marketing

 

12,671

 

 

 

11,043

 

General and administrative

 

13,515

 

 

 

14,972

 

Restructuring costs

 

 

 

 

2,662

 

Total operating expenses

 

32,071

 

 

 

33,539

 

Loss from operations

 

(8,472

)

 

 

(14,389

)

Other income, net

 

 

 

Interest expense

 

(962

)

 

 

(1

)

Interest income

 

515

 

 

 

389

 

Other income (expense), net

 

(37

)

 

 

25

 

Change in fair value of contingent earn-out liability

 

374

 

 

 

8,976

 

Change in fair value of contingently issuable/returnable common stock liability/asset

 

1,492

 

 

 

1,653

 

Change in fair value of public warrant liability

 

2,044

 

 

 

1,721

 

Total other income, net

 

3,426

 

 

 

12,763

 

Loss before income taxes

 

(5,046

)

 

 

(1,626

)

(Benefit) provision for income taxes

 

(37

)

 

 

63

 

Net loss

$

(5,009

)

 

$

(1,689

)

Net loss attributable to common stockholders – basic and diluted

$

(5,009

)

 

$

(1,689

)

 

 

 

 

Weighted average common shares outstanding – basic and diluted

 

177,057,656

 

 

 

160,808,391

 

Net loss per share – basic and diluted

$

(0.03

)

 

$

(0.01

)

 

 

 

 

Net income (loss)

$

(5,009

)

 

$

(1,689

)

Other comprehensive income (loss)

 

 

 

Cumulative translation adjustment

 

28

 

 

 

(46

)

Total other comprehensive income (loss)

 

28

 

 

 

(46

)

Total comprehensive loss

$

(4,981

)

 

$

(1,735

)

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

 

 

March 31, 2026

 

December 31, 2025

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

56,081

 

 

$

49,150

 

Marketable securities

 

4,992

 

 

 

19,885

 

Accounts receivable, net

 

42,713

 

 

 

30,841

 

Inventory

 

8,256

 

 

 

9,317

 

Current portion of contract assets

 

1,199

 

 

 

878

 

Current portion of commission asset

 

5,644

 

 

 

6,062

 

Prepaid expenses and other current assets

 

33,094

 

 

 

35,169

 

Total current assets

 

151,979

 

 

 

151,302

 

Contract assets, noncurrent

 

12

 

 

 

15

 

Commission asset, noncurrent

 

7,728

 

 

 

7,867

 

Property and equipment, net

 

127,839

 

 

 

127,522

 

Operating lease right-of-use assets

 

11,871

 

 

 

12,303

 

Other assets

 

5,210

 

 

 

5,400

 

Total assets

$

304,639

 

 

$

304,409

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

17,089

 

 

$

9,770

 

Accrued expenses and other current liabilities

 

30,345

 

 

 

35,293

 

Current portion of deferred revenue

 

75,314

 

 

 

74,924

 

Current portion of operating lease liabilities

 

3,116

 

 

 

2,989

 

Total current liabilities

 

125,864

 

 

 

122,976

 

Deferred revenue, noncurrent

 

17,036

 

 

 

16,716

 

Long-term debt

 

28,665

 

 

 

28,596

 

Operating lease liabilities, noncurrent

 

10,190

 

 

 

10,654

 

Contingent earn-out liability, noncurrent

 

 

 

 

374

 

Contingently issuable common stock liability, noncurrent

 

392

 

 

 

1,809

 

Public warrant liability, noncurrent

 

1,818

 

 

 

3,862

 

Total liabilities

 

183,965

 

 

 

184,987

 

 

 

 

 

Stockholders’ equity:

 

 

 

Preferred stock, $0.0001 par value; 100,000,000 authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025

 

 

 

 

 

Common stock, $0.0001 par value; 1,100,000,000 shares authorized at March 31, 2026 and December 31, 2025; 179,458,233 and 175,399,488 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively

 

18

 

 

 

18

 

Additional paid-in capital

 

513,580

 

 

 

507,347

 

Accumulated other comprehensive loss

 

(113

)

 

 

(141

)

Accumulated deficit

 

(392,811

)

 

 

(387,802

)

Stockholders’ equity

 

120,674

 

 

 

119,422

 

Total liabilities and stockholders’ equity

$

304,639

 

 

$

304,409

 

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

 

 

 

Three Months Ended

March 31,

 

 

 

2026

 

 

 

2025

 

Cash flows from operating activities:

 

 

 

Net loss

$

(5,009

)

 

$

(1,689

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

6,801

 

 

 

5,530

 

Write-off of inventory and change in inventory reserve

 

60

 

 

 

2

 

Loss on disposal of property and equipment

 

184

 

 

 

321

 

Stock-based compensation

 

5,587

 

 

 

4,879

 

Amortization of debt issuance costs

 

282

 

 

 

 

Amortization of premium on marketable securities, net of change in accrued interest

 

168

 

 

 

71

 

Non-cash lease expense

 

432

 

 

 

424

 

Change in allowance for expected credit losses

 

 

 

 

41

 

Change in fair value of earn-out liability

 

(374

)

 

 

(8,976

)

Change in fair value of contingently issuable/returnable common stock liability/asset

 

(1,492

)

 

 

(1,653

)

Change in fair value of public warrant liability

 

(2,044

)

 

 

(1,721

)

Changes in operating assets and liabilities

 

 

 

Accounts receivable

 

(11,872

)

 

 

(6,124

)

Inventory

 

1,657

 

 

 

7,172

 

Commission assets

 

557

 

 

 

203

 

Contract assets

 

(318

)

 

 

(321

)

Other assets

 

265

 

 

 

82

 

Prepaid expenses and other current assets

 

(1,883

)

 

 

(3,859

)

Accounts payable

 

7,614

 

 

 

2,780

 

Deferred revenue

 

710

 

 

 

500

 

Accrued expenses and other current liabilities

 

(4,167

)

 

 

(71

)

Operating lease liability

 

(337

)

 

 

(130

)

Net cash used in operating activities

 

(3,179

)

 

 

(2,539

)

Cash flows from investing activities:

 

 

 

Development of internal-use software

 

(1,223

)

 

 

(1,556

)

Purchases of property and equipment

 

(3,742

)

 

 

(12,730

)

Purchases of marketable securities

 

 

 

 

(9,875

)

Proceeds from maturities of marketable securities

 

14,725

 

 

 

14,800

 

Net cash provided by (used in) investing activities

 

9,760

 

 

 

(9,361

)

Cash flows from financing activities:

 

 

 

Proceeds from exercise of stock options

 

322

 

 

 

20

 

Net cash provided by financing activities

 

322

 

 

 

20

 

Effect of exchange rate changes on cash and cash equivalents

 

28

 

 

 

(46

)

Net increase (decrease) in cash and cash equivalents

 

6,931

 

 

 

(11,926

)

Cash and cash equivalents

 

 

 

Cash and cash equivalents at beginning of period

 

49,150

 

 

 

37,015

 

Cash and cash equivalents at end of period

$

56,081

 

 

$

25,089

 

EVOLV TECHNOLOGY

SUMMARY OF KEY OPERATING STATISTICS

(Unaudited)

 

 

 

 

 

Three Months Ended or as of,

($ in thousands)

 

March 31,

2025

 

June 30,

2025

 

September 30,

2025

 

December 31,

2025

 

March 31,

2026

New customers

 

54

 

 

63

 

 

62

 

 

64

 

 

48

Annual recurring revenue

$

105,990

 

$

110,516

 

$

117,200

 

$

120,467

 

$

127,300

Recurring revenue

$

25,753

 

$

26,678

 

$

30,120

 

$

29,547

 

$

31,176

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

(In thousands)

(Unaudited)

 

 

 

 

 

Three Months Ended,

 

 

March 31,

2025

 

June 30,

2025

 

September 30,

2025

 

December 31,

2025

 

March 31,

2026

Operating expenses, GAAP

$

33,539

 

 

$

33,711

 

 

$

29,902

 

 

$

26,613

 

 

$

32,071

 

Stock-based compensation

 

(4,660

)

 

 

(5,265

)

 

 

(5,121

)

 

 

(5,006

)

 

 

(5,272

)

Non-recurring employee restructuring and other separation costs

 

(2,137

)

 

 

(827

)

 

 

(6

)

 

 

 

 

 

 

Other non-recurring legal and regulatory costs

 

(3,561

)

 

 

(5,979

)

 

 

36

 

 

 

2,225

 

 

 

99

 

Adjusted operating expenses

$

23,181

 

 

$

21,640

 

 

$

24,811

 

 

$

23,832

 

 

$

26,898

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP INCOME (LOSS) FROM OPERATIONS TO ADJUSTED OPERATING INCOME (LOSS)

(In thousands)

(Unaudited)

 

 

Three Months Ended

March 31,

 

 

2026

 

 

 

2025

 

Revenue

$

46,328

 

 

$

32,007

 

Cost of revenue

 

22,729

 

 

 

12,857

 

Gross profit, GAAP

 

23,599

 

 

 

19,150

 

Stock-based compensation

 

315

 

 

 

219

 

Amortization of capitalized stock-based compensation

 

161

 

 

 

103

 

Adjusted gross profit

$

24,075

 

 

$

19,472

 

 

 

 

 

Gross margin %

 

50.9

%

 

 

59.8

%

Impact of adjustments from Gross profit, GAAP to Adjusted gross profit

 

1.1

%

 

 

1.0

%

Adjusted gross margin %

 

52.0

%

 

 

60.8

%

 

 

Three Months Ended

March 31,

 

 

2026

 

 

 

2025

 

Loss from operations, GAAP

$

(8,472

)

 

$

(14,389

)

Stock-based compensation

 

5,587

 

 

 

4,879

 

Amortization of capitalized stock-based compensation

 

161

 

 

 

103

 

Non-recurring employee restructuring and other separation costs

 

 

 

 

2,137

 

Other non-recurring legal and regulatory costs

 

(99

)

 

 

3,561

 

Adjusted loss from operations

$

(2,823

)

 

$

(3,709

)

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA AND NET PROFIT MARGIN TO ADJUSTED EBITDA MARGIN

(In thousands)

(Unaudited)

 

 

 

 

 

Three Months Ended

March 31,

 

 

 

2026

 

 

 

2025

 

Net loss

$

(5,009

)

 

$

(1,689

)

Depreciation and amortization

 

6,801

 

 

 

5,530

 

Stock-based compensation

 

5,587

 

 

 

4,879

 

Interest expense (income)

 

447

 

 

 

(388

)

(Benefit) provision for income taxes

 

(37

)

 

 

63

 

Change in fair value of contingent earn-out liability

 

(374

)

 

 

(8,976

)

Change in fair value of contingently issuable/returnable common stock liability/asset

 

(1,492

)

 

 

(1,653

)

Change in fair value of public warrant liability

 

(2,044

)

 

 

(1,721

)

Loss on disposal of leased equipment*

 

164

 

 

 

321

 

Non-recurring employee restructuring and other separation costs

 

 

 

 

2,137

 

Other non-recurring legal and regulatory costs

 

(99

)

 

 

3,561

 

Adjusted EBITDA

$

3,944

 

 

$

2,064

 

 

 

 

 

Net profit margin %

 

(10.8

)%

 

 

(5.3

)%

Impact of adjustments from Net loss to Adjusted EBITDA

 

19.3

%

 

 

11.7

%

Adjusted EBITDA margin %

 

8.5

%

 

 

6.4

%

 

*Q1 2025 figure reflects refinements of our adjusted EBITDA calculation in Q3 2025, applied consistently to all prior quarters.

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

(In thousands, except share and per share data)

(Unaudited)

 

 

 

 

 

Three Months Ended

March 31,

 

 

 

2026

 

 

 

2025

 

Net loss

$

(5,009

)

 

$

(1,689

)

Stock-based compensation

 

5,587

 

 

 

4,879

 

Amortization of capitalized stock-based compensation

 

161

 

 

 

103

 

Change in fair value of contingent earn-out liability

 

(374

)

 

 

(8,976

)

Change in fair value of contingently issuable/returnable common stock liability/asset

 

(1,492

)

 

 

(1,653

)

Change in fair value of public warrant liability

 

(2,044

)

 

 

(1,721

)

Non-recurring employee restructuring and other separation costs

 

 

 

 

2,137

 

Other non-recurring legal and regulatory costs

 

(99

)

 

 

3,561

 

Adjusted loss

$

(3,270

)

 

$

(3,359

)

 

 

 

 

Weighted average common shares outstanding – diluted

 

177,057,656

 

 

 

160,808,391

 

 

 

 

 

Net loss per share – diluted

$

(0.03

)

 

$

(0.01

)

Impact of adjustments from Net loss to Adjusted loss

 

0.01

 

 

 

(0.01

)

Adjusted loss per share – diluted

$

(0.02

)

 

$

(0.02

)

 

Three Months Ended,

 

March 31,

2025

 

June 30,

2025

 

September 30,

2025

 

December 31,

2025

 

March 31,

2026

Stock-based compensation:

 

 

 

 

 

 

 

 

 

Cost of product revenue

$

8

 

$

17

 

$

32

 

$

39

 

$

58

Cost of subscription revenue

 

137

 

 

167

 

 

146

 

 

135

 

 

138

Cost of service revenue

 

67

 

 

74

 

 

72

 

 

80

 

 

100

Cost of license fee and other revenue

 

7

 

 

24

 

 

19

 

 

20

 

 

19

Research and development

 

1,115

 

 

1,154

 

 

1,227

 

 

1,252

 

 

1,280

Sales and marketing

 

1,048

 

 

1,710

 

 

1,480

 

 

1,330

 

 

1,566

General and administrative

 

1,972

 

 

2,401

 

 

2,414

 

 

2,424

 

 

2,426

Restructuring costs

 

525

 

 

 

 

 

 

 

 

Total stock-based compensation

$

4,879

 

$

5,547

 

$

5,390

 

$

5,280

 

$

5,587

 

 

 

 

 

 

 

 

 

 

Amortization of capitalized stock-based compensation:

 

 

 

 

 

 

 

 

 

Cost of subscription revenue

$

59

 

$

60

 

$

63

 

$

82

 

$

86

Cost of service revenue

 

44

 

 

47

 

 

51

 

 

68

 

 

75

Total amortization of capitalized stock-based compensation

$

103

 

$

107

 

$

114

 

$

150

 

$

161

 

 

 

 

 

 

 

 

 

 

Non-recurring employee restructuring and other separation costs:

 

 

 

 

 

 

 

 

 

Cost of service revenue

$

 

$

6

 

$

 

$

 

$

Research and development

 

 

 

31

 

 

 

 

 

 

Sales and marketing

 

 

 

613

 

 

6

 

 

 

 

General and administrative

 

 

 

183

 

 

 

 

 

 

Restructuring costs

 

2,137

 

 

 

 

 

 

 

 

Total non-recurring employee restructuring and other separation costs

$

2,137

 

$

833

 

$

6

 

$

 

$

 

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  265.82
-3.17 (-1.18%)
AAPL  294.80
+2.12 (0.72%)
AMD  448.29
-10.50 (-2.29%)
BAC  50.78
+0.23 (0.45%)
GOOG  383.82
-2.95 (-0.76%)
META  603.00
+4.14 (0.69%)
MSFT  407.77
-4.89 (-1.18%)
NVDA  220.78
+1.34 (0.61%)
ORCL  186.83
-7.01 (-3.62%)
TSLA  433.45
-11.55 (-2.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.